Van Buskirk E M
Ophthalmology. 1982 Mar;89(3):238-41. doi: 10.1016/s0161-6420(82)34811-3.
Particular glaucoma drug hazards for cataract patients include miosis, exacerbation of lens opacity, pupillary block, and the development of systemic adrenergic or cholinergic adverse drug effects or interaction. Each available antiglaucoma drug needs to be selected in individual cases with the knowledge of side effects that are likely to develop. For the glaucoma-cataract patient, a glaucoma regimen need be designed to minimize visual impairment, to minimize exacerbation of cataract, and to prevent introduction of new ocular disorders. At the time of cataract surgery, the regimen should be reassessed to maximize a smooth operative course and minimize systemic operative and anesthetic complications.
青光眼药物对白内障患者的特殊危害包括瞳孔缩小、晶状体混浊加重、瞳孔阻滞以及全身性肾上腺素能或胆碱能药物不良反应或相互作用的发生。在每种情况下，都需要在了解可能出现的副作用的基础上选择每种可用的抗青光眼药物。对于青光眼合并白内障患者，需要设计一种青光眼治疗方案，以尽量减少视力损害，尽量减少白内障的加重，并防止出现新的眼部疾病。在白内障手术时，应重新评估治疗方案，以最大程度地实现手术过程顺利，并尽量减少全身性手术和麻醉并发症。
